:max_bytes(133120)/d1qcnx2r3xkirq.cloudfront.net/pubmed-llm-images/40047199/0b10464f2088a89b3e55d4849f5eb9f9_wm.png)
Prevalence and Risk Factors of L-Asparaginase-Related Thrombosis Among Acute Lymphoblastic Lymphoma Patients in a Resource-Limited Setup of Sub-Saharan Region.
Summary: Imagine you have a blood cancer called leukemia. Doctors use a strong medicine called L-asparaginase to fight it. This medicine works very well, but it has a dangerous side effect: it can cause blood clots. Doctors at a hospital in Africa looked at 152 patients taking this drug. They found that about 1 in 10 patients got a blood clot, mostly in the brain. Patients who were over 40 years old or took a long time to get better had the highest risk. While the number of blood clots is similar to other places in the world, more people died from them because the hospital didn't have enough resources. Doctors need to watch older patients very closely to keep them safe.
Tags
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Venous Thrombosis
Thrombosis
Male
Lymphoma
Leukemia
Remission Induction
Asparaginase